MX9709561A - Reverse fluorocarbon emulsion compositions for drug delivery. - Google Patents

Reverse fluorocarbon emulsion compositions for drug delivery.

Info

Publication number
MX9709561A
MX9709561A MX9709561A MX9709561A MX9709561A MX 9709561 A MX9709561 A MX 9709561A MX 9709561 A MX9709561 A MX 9709561A MX 9709561 A MX9709561 A MX 9709561A MX 9709561 A MX9709561 A MX 9709561A
Authority
MX
Mexico
Prior art keywords
drug delivery
emulsion compositions
fluorocarbon emulsion
emulsions
phase
Prior art date
Application number
MX9709561A
Other languages
Spanish (es)
Other versions
MXPA97009561A (en
Inventor
Thomas E Tarara
Jeffry G Weers
Leo A Trevino
Alexey Kabalnov
Luis A Dellamary
Gina M Hopper
Helen M Ranney
David H Klein
Timothy J Pelura
Original Assignee
Aliance Pharmaceutical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aliance Pharmaceutical Corp filed Critical Aliance Pharmaceutical Corp
Publication of MX9709561A publication Critical patent/MX9709561A/en
Publication of MXPA97009561A publication Critical patent/MXPA97009561A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

A polar liquid-in-perfluorochemical emulsion or microemulsion for use in delivery of therapeutic or diagnostic agents. These compositions are formed by combining a discontinuous aqueous phase, a continuous fluorocarbon phase and a nonfluorinated surfactant. Further, the polar liquid-in-fluorochemical emulsions may be used to form multiple emulsions having an aqueous continuous phase. Such emulsions and microemulsions are suitable for the administration of pharmaceutical agents including genetic material.
MXPA/A/1997/009561A 1995-06-07 1997-12-04 Compositions of the inverse huorocarbobo emulsion (private) for the supply of medicame MXPA97009561A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48761295A 1995-06-07 1995-06-07
US487612 1995-06-07

Publications (2)

Publication Number Publication Date
MX9709561A true MX9709561A (en) 1998-10-31
MXPA97009561A MXPA97009561A (en) 1999-01-11

Family

ID=

Also Published As

Publication number Publication date
PL323931A1 (en) 1998-04-27
CA2222063A1 (en) 1996-12-19
HUP9900879A2 (en) 1999-08-30
WO1996040057A2 (en) 1996-12-19
KR19990022354A (en) 1999-03-25
HU9900879D0 (en) 1999-05-28
AU704918B2 (en) 1999-05-06
EP0833608A2 (en) 1998-04-08
NO975321L (en) 1998-01-27
NO975321D0 (en) 1997-11-19
CN1195981A (en) 1998-10-14
AU6153796A (en) 1996-12-30
JPH11508237A (en) 1999-07-21
WO1996040057A3 (en) 1997-02-20
IL122249A0 (en) 1998-04-05

Similar Documents

Publication Publication Date Title
WO1996040057A3 (en) Reverse fluorocarbon emulsion compositions for drug delivery
AU643690B2 (en) Injectable multi-phase emulsions
KR950031069A (en) How to suppress bone loss and lower serum cholesterol
DE69842121D1 (en) OMEGA-3 FATTY ACID PHARMACEUTICAL COMPOSITIONS
TNSN94099A1 (en) NEW EMULSION COMPOSITIONS
SE9503143D0 (en) New preparation
IS4224A (en) A pharmaceutical formulation in the form of a droplet containing a short-acting calcium antidote of the dihydropyridine antidepressant
BG103552A (en) Therapeutical forms
YU2494A (en) PHARMACEUTICAL FORMULATION FOR TREATMENT OF NICOTINE SUBSTANCE
ATE213940T1 (en) MEDICINAL PREPARATION FOR PARENTERAL APPLICATION CONTAINING AMIODARON
ITMI921831A1 (en) PHARMACEUTICAL COMPOSITIONS IN THE FORM OF MICROEMULSIONS OR BIOADHESIVE LIPOSOMIAL DISPERSIONS FOR THE TRANSMUCOSAL ADMINISTRATION OF PEPTIDAL SUBSTANCES AND PHARMACOLOGICALLY ACTIVE PROTEINS
WO2003082222A3 (en) Cosmetic or pharmaceutical low-viscosity (atomizable) o/w emulsions containing phospholipids
DE50012930D1 (en) EMULSIFY FREE WATER-IN-OIL WATER-DISPERSED SYSTEMS
AP2002002384A0 (en) Parenteral cisplatin emulsion
DE69926633D1 (en) INJECTABLE MEDICINE PREORMULATIONS OF PARTRICINE DERIVATIVES
SE9402455L (en) Biskiktspreparat